Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection

Por Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Terpos E
Publicado em 2020-07-01

Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis

Por Kostopoulos, I V, Paterakis, G, Pavlidis, D, Kastritis, E, Terpos, E, Tsitsilonis, O E, Papadhimitriou, S I
Publicado no Blood Cancer J (2017)

Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging

Por Kastritis, E, Gavriatopoulou, M, Dimopoulos, M A, Eleutherakis-Papaiakovou, E, Kanellias, N, Roussou, M, Pamboucas, C, Toumanidis, S T, Terpos, E
Publicado no Blood Cancer J (2015)

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma

Por Spanoudakis, E, Papoutselis, M, Terpos, E, Dimopoulos, M A, Tsatalas, C, Margaritis, D, Rahemtulla, A, Kotsianidis, I, Karadimitris, A
Publicado no Blood Cancer J (2016)

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

Por Raje, N, Vadhan-Raj, S, Willenbacher, W, Terpos, E, Hungria, V, Spencer, A, Alexeeva, Y, Facon, T, Stewart, A K, Feng, A, Braun, A, Balakumaran, A, Roodman, G D
Publicado no Blood Cancer J (2016)

Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment

Por Terpos, E, Migkou, M, Christoulas, D, Gavriatopoulou, M, Eleutherakis-Papaiakovou, E, Kanellias, N, Iakovaki, M, Panagiotidis, I, Ziogas, D C, Fotiou, D, Kastritis, E, Dimopoulos, M A
Publicado no Blood Cancer J (2016)

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

Por Gavalas, N G, Tsiatas, M, Tsitsilonis, O, Politi, E, Ioannou, K, Ziogas, A C, Rodolakis, A, Vlahos, G, Thomakos, N, Haidopoulos, D, Terpos, E, Antsaklis, A, Dimopoulos, M A, Bamias, A
Publicado em 2012

High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomat...

Por Terpos, E, Christoulas, D, Kastritis, E, Bagratuni, T, Gavriatopoulou, M, Roussou, M, Papatheodorou, A, Eleutherakis-Papaiakovou, E, Kanellias, N, Liakou, C, Panagiotidis, I, Migkou, M, Kokkoris, P, Moulopoulos, L A, Dimopoulos, M A
Publicado no Blood Cancer J (2016)

Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit

Por Dimopoulos, M A, Roussou, M, Gavriatopoulou, M, Fotiou, D, Ziogas, D C, Migkou, M, Panagiotidis, I, Eleutherakis-Papaiakovou, E, Kanellias, N, Psimenou, E, Marinaki, S, Bacharaki, D, Mparmparoussi, D, Matsouka, C, Giannouli, S, Terpos, E, Kastritis, E
Publicado no Blood Cancer J (2017)

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel

Por Caers, J., Paiva, B., Zamagni, E., Leleu, X., Bladé, J., Kristinsson, S. Y., Touzeau, C., Abildgaard, N., Terpos, E., Heusschen, R., Ocio, E., Delforge, M., Sezer, O., Beksac, M., Ludwig, H., Merlini, G., Moreau, P., Zweegman, S., Engelhardt, M., Rosiñol, L.
Publicado no J Hematol Oncol (2018)

Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib

Por Kastritis, E, Gavriatopoulou, M, Roussou, M, Fotiou, D, Ziogas, D C, Migkou, M, Eleutherakis-Papaiakovou, E, Panagiotidis, I, Kanellias, N, Psimenou, E, Papadopoulou, E, Pamboucas, C, Manios, E, Gakiopoulou, H, Ntalianis, A, Tasidou, A, Giannouli, S, Terpos, E, Dimopoulos, M A
Publicado no Blood Cancer J (2017)

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group

Por Hillengass, J, Moulopoulos, L A, Delorme, S, Koutoulidis, V, Mosebach, J, Hielscher, T, Drake, M, Rajkumar, S V, Oestergaard, B, Abildgaard, N, Hinge, M, Plesner, T, Suehara, Y, Matsue, K, Withofs, N, Caers, J, Waage, A, Goldschmidt, H, Dimopoulos, M A, Lentzsch, S, Durie, B, Terpos, E
Publicado no Blood Cancer J (2017)